300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Manufacturing
Real Estate
Sporting Goods
Social Media
FinTech
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Finance
Sustainability
Hardware
Biotech
Transportation
Digital Media
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Japan
Puerto Rico
Poland
Cameroon
Guernsey
China
Colombia
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology VC Funds & Investors in Sweden (October 2026)

The most active venture capital funds investing in Sweden Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Sweden Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Almi Invest
VC Fund
32 Sweden, Norway, United States Venture - Series Unknown, Seed Software, Health Care, Information Technology $226k–$3.5M
Chalmers Ventures AB
VC Fund
29 Sweden, United States Pre-Seed, Seed, Venture - Series Unknown Software, Biotechnology, Information Technology $5.8k–$3.5M
Industrifonden
VC Fund
17 Sweden, United States, Denmark Series A, Venture - Series Unknown Biotechnology, Software, Information Technology $2.3M–$21M
Sciety
VC Fund
14 Sweden, Ukraine Seed, Series A, Venture - Series Unknown Health Care, Biotechnology, Medical $125k–$6.9M
Navigare Ventures
VC Fund
8 Sweden, Denmark Seed, Venture - Series Unknown, Series A Biotechnology, Manufacturing, Energy $470k–$21M
Novo Holdings
VC Fund
6 United States, Denmark, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $9.5M–$135M
HealthCap
VC Fund
5 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $6M–$92M
Karolinska
VC Fund
5 Sweden, Denmark, United States Venture - Series Unknown, Seed Biotechnology, Health Care, Pharmaceutical $3.2M–$10M
SEB Venture Capital
VC Fund
4 Sweden, Denmark, United Kingdom Series A, Series B Software, Information Technology, FinTech $1.2M–$23M
Norrsken VC
VC Fund
4 Sweden, United Kingdom, Germany Seed, Series A, Venture - Series Unknown Software, Food and Beverage, Artificial Intelligence $893k–$156M
Boehringer Ingelheim Venture Fund
VC Fund
3 United States, Germany, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.8M–$50M
Crowberry Capital
VC Fund
3 Iceland, Denmark, Finland Seed, Series A, Pre-Seed Software, Gaming, Health Care $400k–$17M
Voima Ventures
VC Fund
3 Finland, Sweden, Norway Seed, Pre-Seed, Series A Biotechnology, Health Care, Artificial Intelligence $464k–$30M
Bånt AB
VC Fund
3 Sweden Seed Biotechnology, Manufacturing, Food Processing $1.3M–$9.1M
EIR Ventures
VC Fund
3 Denmark, Sweden, United States Series A, Seed Biotechnology, Health Care, Therapeutics $20M–$73M
BackingMinds
VC Fund
3 Sweden, Denmark, Finland Seed, Venture - Series Unknown, Pre-Seed Software, SaaS, Energy $826k–$40M
I Love Lund
VC Fund
3 Sweden Venture - Series Unknown, Pre-Seed, Seed Biotechnology, Medical, Forestry $38k–$2.2M
Inventure
VC Fund
3 Finland, Sweden, United States Seed, Series A, Series B Software, Information Technology, Artificial Intelligence $549k–$25M
Partnerinvest Norr
VC Fund
3 Sweden, United States Seed, Venture - Series Unknown Software, Manufacturing, Information Technology $359k–$4M
Fåhraeus Startup and Growth
VC Fund
3 Sweden, Denmark, Finland Seed, Venture - Series Unknown, Series A Medical, Health Care, Biotechnology $851k–$7.3M
Flerie Invest
VC Fund
3 Sweden, United States, United Kingdom Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Pharmaceutical $2.5M–$75M
FBG Invest
VC Fund
3 Sweden Seed Biotechnology, Manufacturing, Food Processing $1.3M–$9.1M
Hadean Ventures
VC Fund
3 Sweden, Norway, Austria Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $2M–$79M
Colibri Ventures
VC Fund
2 Sweden, Mexico Seed, Series A, Venture - Series Unknown Gaming, Finance, Wellness $6M–$6M
Additio Investment Group
VC Fund
2 United Kingdom, Sweden Series A Health Care, Biotechnology, Medical $4.3M–$12M
Länsförsäkringar
VC Fund
2 Sweden Seed, Pre-Seed, Post-IPO Equity Real Estate, Biotechnology, Manufacturing $484k–$107M
Life Science Invest
VC Fund
2 Sweden Seed, Pre-Seed Medical, Biotechnology, Biopharma $310k–$4.6M
Noaber
VC Fund
2 The Netherlands, Israel, Germany Seed, Series A, Pre-Seed Health Care, Medical, Fitness $423k–$20M
Gunnar Nilsson Cancer Foundation
VC Fund
2 Sweden Seed, Series A Medical, Genetics, Biotechnology
Segulah Medical Acceleration
VC Fund
2 Sweden, United Kingdom, Germany Series D, Series A, Seed Health Care, Medical Device, Biotechnology $8.5M–$245M
LU Holding
VC Fund
2 Sweden Seed, Angel, Pre-Seed Biotechnology, Software, Medical Device
Faro Capital
VC Fund
2 Sweden, United States Series A, Seed, Venture - Series Unknown Biotechnology, Gaming, Medical $2.8M–$25M
LIU Invest
VC Fund
2 Sweden Seed, Pre-Seed Biotechnology, Information Technology, AgTech $88k–$1.4M
ARCH Venture Partners
VC Fund
2 United States, China, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $9.1M–$230M
Glass Wall Syndicate
VC Fund
2 United States, India, Sweden Seed, Pre-Seed, Series C Biotechnology, Food and Beverage, Health Care $845k–$5.7M
Nordic Science Investments
VC Fund
2 Finland, Sweden, United States Seed, Pre-Seed, Series A Biotechnology, Medical, Health Diagnostics $373k–$34M
Nina Capital
VC Fund
2 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $529k–$21M
Bertebos Foundation
VC Fund
2 Sweden Seed Biotechnology, Manufacturing, Food Processing
Kale United
VC Fund
2 Sweden, United Kingdom, Canada Seed, Pre-Seed Food and Beverage, Food Processing, Biotechnology $100k–$2.5M
Plantbase Foundation
VC Fund
2 Sweden Seed Biotechnology, Manufacturing, Food Processing
Inven2
VC Fund
1 Sweden Series A Therapeutics, Biotechnology, Pharmaceutical
Social Starts
VC Fund
1 United States, Germany, United Kingdom Seed, Series A Software, Health Care, Artificial Intelligence
Monesi
VC Fund
1 Sweden Pre-Seed Life Science, Biotechnology
HJKK Didrikson
VC Fund
1 Sweden Seed Biopharma, Biotechnology, Pharmaceutical
Phase2Phase Biopharma
VC Fund
1 Sweden Seed Biopharma, Biotechnology, Pharmaceutical
Inter Ikea
VC Fund
1 Germany, Sweden, Denmark Seed, Corporate Round Software, Furniture, Health Care
Unruly Capital
VC Fund
1 United Kingdom, United States, Germany Seed, Pre-Seed Biotechnology, CleanTech, Manufacturing
Nxt2b
VC Fund
1 Sweden Series A Health Care, Biotechnology, Health Diagnostics
KTH Holding
VC Fund
1 Sweden Seed, Pre-Seed Software, Information Technology, Biotechnology
Nordic Foodtech VC
VC Fund
1 Finland, Sweden, Denmark Seed, Series A Biotechnology, Life Science, Water
Access all 331 VC funds in Sweden Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Almi Invest
VC Fund · Stockholm, Stockholms Lan, Sweden · 32 investments in Sweden Biotechnology startups

Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Venture - Series Unknown, Seed
  • Geography: Sweden, Norway, United States

Investor stats

  • Total investments: 543
  • Round size: Seed $226k–$2.2M; Venture - Series Unknown $326k–$3.5M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $64M in 2024

Portfolio highlights

  • Indevex AB — Indevex is a science-based and privately owned biotech company from Sweden. A natural and reliable partner, providing evidence based natural nutrition concepts based on the patented NGC™ Formula.
  • Qulsar — Qulsar provides high precision time synchronization solutions for 5G, private mobile, industrial IoT and real time data applications and infrastructures. Its solution combines Time Synchronization as a Service (TSaaS) and open and proprietary software running on off the shelf (COTS) hardware. Qulsar's solutions span multiple precision levelsand slashes cost of ownership and operation.
  • Boka konferens — Boka konferens provides an online booking platform that allows users to browse and book conference rooms and venue space for corporate offices. Their products serve consumers. For inquiries, their telephone number and email address are available on their website.
Show all investments...

Chalmers Ventures AB
VC Fund · Göteborg, Vastra Gotaland, Sweden · 29 investments in Sweden Biotechnology startups

We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Pre-Seed, Seed, Venture - Series Unknown
  • Geography: Sweden, United States

Investor stats

  • Total investments: 282
  • Round size: Seed $237k–$2.3M; Pre-Seed $5.8k–$349k; Venture - Series Unknown $357k–$3.5M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
  • Solinide Photonics — Solinide Photonics is a technological company spun out of Chalmers University of Technology. It develops ultra-efficient silicon nitride-based photonic circuits and microcomb technologies.
  • InfiniNode Technologies AB — InfiniNode is a semiconductor IP company that seeks to enable efficient data movement in future compute systems.
Show all investments...

Industrifonden
VC Fund · Stockholm, Stockholms Lan, Sweden · 17 investments in Sweden Biotechnology startups

Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Information Technology
  • Stage:Series A, Venture - Series Unknown
  • Geography: Sweden, United States, Denmark

Investor stats

  • Total investments: 204
  • Round size: Series A $3.3M–$21M; Venture - Series Unknown $2.3M–$20M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Yangi — Yangi is a provider of environmentally friendly packaging solutions.
  • Avtal24 — Avtal24 offers in an easily accessible manner agreements for both private individuals and companies. They believe in making the law available to everyone and they want everyone to have access to legal security. With us, you write agreements online or together with a lawyer by phone. Always at a fixed price. With high legal expertise, innovativetechnology and great focus on customer benefit and offer the market's most accessible legal services.Avtal24 was founded in 2004 and is headquartered in Stockholm, Sweden.
  • Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Show all investments...

Sciety
VC Fund · Stockholm, Stockholms Lan, Sweden · 14 investments in Sweden Biotechnology startups

Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Sweden, Ukraine

Investor stats

  • Total investments: 47
  • Round size: Seed $125k–$2.3M; Series A $457k–$6.5M; Venture - Series Unknown $1.6M–$6.9M
  • Lead/follow: 91% lead, 9% follow

Portfolio highlights

  • NEOGAP Therapeutics — NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.
  • Everdrone — Advanced drone operations for public safety and emergency response
  • Single Technologies — SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq.
Show all investments...

Navigare Ventures
VC Fund · Stockholm, Stockholms Lan, Sweden · 8 investments in Sweden Biotechnology startups, 8 in the past 12 months

Welcome to Navigare Ventures. We invest in transformational early-stage companies at the frontier of science and technology.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Energy
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Sweden, Denmark

Investor stats

  • Total investments: 31
  • Round size: Seed $470k–$6M; Series A $7.3M–$21M; Venture - Series Unknown $858k–$8.5M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • TERASi — Scalable hardware for 6G and beyond.
  • EnginZyme — Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at industrial scale.
  • Pixelgen Technologies — Understand the role of proteins in cellular organization with spatial proteomics. Get ahead in the field of proteomics with us.
Show all investments...

Novo Holdings
VC Fund · Hellerup, Hovedstaden, Denmark · 6 investments in Sweden Biotechnology startups

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 407
  • Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $30M–$118M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $165M in 2018

Portfolio highlights

  • IVERIC bio — IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inheritedretinal diseases.
  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 5 investments in Sweden Biotechnology startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 141
  • Round size: Series A $6M–$73M; Series B $12M–$92M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $179M in 2024

Portfolio highlights

  • Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
  • AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

Karolinska
VC Fund · Solna, Stockholms Lan, Sweden · 5 investments in Sweden Biotechnology startups

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Venture - Series Unknown, Seed
  • Geography: Sweden, Denmark, United States

Investor stats

  • Total investments: 32
  • Round size: Venture - Series Unknown $3.2M–$10M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • BOOST Pharma — BOOST Pharma is developing BT-101, an off-the-shelf therapy for early intervention in children with severe osteogenesis imperfecta (OI).
  • Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
  • Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Show all investments...

SEB Venture Capital
VC Fund · Stockholm, Stockholms Lan, Sweden · 4 investments in Sweden Biotechnology startups

SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.

Show more...

Investment focus

  • Industry: Software, Information Technology, FinTech
  • Stage:Series A, Series B
  • Geography: Sweden, Denmark, United Kingdom

Investor stats

  • Total investments: 77
  • Round size: Series A $1.2M–$7.4M; Series B $2.2M–$23M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $300M in 1995

Portfolio highlights

  • Apica — Apica provides the most effective technology for optimizing the performance of cloud and mobile applications. The Apica WebExcellence Suite offers companies and developers alike easy-to-use, cloud-based load testing and web performance monitoring tools to test applications for maximum capacity, daily performance, improved load times, and protectionfrom peak load.
  • MobileTag — Mobile Tag, the European leader in mobile barcode solutions, continues to innovate with the launch of its latest application: mobiletag Universal Reader and shopping.Mobile Tag is behind the creation of the flashcode, the standard 2D barcode used by operators in France. This type of Datamatrix barcode is used by the biggest companies indisplay, transportation, distribution, the pharmaceutical industry, and more.Mobile Tag has always tried to develop new technology from the consumer's point of view, and the mobiletag Universal Reader & shopping is no exception.The concept behind this application is to send, receive and share information and best prices to everyone and for everyone through all standardized barcodes.Scanning a barcode with your mobile phone is simply taking a picture of it with your phone, using the mobiletag application. Mobile tag is free!
  • CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
Show all investments...

Norrsken VC
VC Fund · Stockholm, Stockholms Lan, Sweden · 4 investments in Sweden Biotechnology startups

We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.

Show more...

Investment focus

  • Industry: Software, Food and Beverage, Artificial Intelligence
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Sweden, United Kingdom, Germany

Investor stats

  • Total investments: 108
  • Round size: Seed $893k–$14M; Series A $4.4M–$56M; Venture - Series Unknown $1.1M–$156M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $346M in 2024

Portfolio highlights

  • Biorce — Meet the world's first AI clinical trials assistant! We bring innovative technologies to revolutionize healthcare and drug development faster & more efficiently
  • Verse — Define & achieve your financial and emissions reduction goals with Aria, a software platform that helps companies buy and manage clean power.
  • Endra — Endra is a purpose-built platform for modern MEP engineering. Generate 3D models and drawings, sync with Revit and enjoy coordinated design workflows.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 3 investments in Sweden Biotechnology startups, 7 in the past 12 months

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 108
  • Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2018

Portfolio highlights

  • Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Cloverleaf Bio — Cloverleaf Bio | Developing a new class of RNA therapeutics to revolutionize cancer therapy.
Show all investments...

Crowberry Capital
VC Fund · Reykjavík, Gullbringusysla, Iceland · 3 investments in Sweden Biotechnology startups

Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.

Show more...

Investment focus

  • Industry: Software, Gaming, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Iceland, Denmark, Finland

Investor stats

  • Total investments: 52
  • Round size: Seed $1.6M–$4.4M; Pre-Seed $400k–$1.3M; Series A $5.7M–$17M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: May invest from a new fund soon — raised $90M in 2021

Portfolio highlights

  • Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
  • SNERPA Power — SNERPA Power develops intelligent energy services.
  • Augmented Hearing — Read more about danish audiology scale-up Augmented Hearing, driving the world's most ambitious audiology solutions and innovations.
Show all investments...

Voima Ventures
VC Fund · Helsinki, Southern Finland, Finland · 3 investments in Sweden Biotechnology startups, 6 in the past 12 months

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden, Norway

Investor stats

  • Total investments: 61
  • Round size: Seed $1M–$5.9M; Pre-Seed $464k–$2.1M; Series A $3.9M–$30M
  • Lead/follow: 64% lead, 36% follow
  • Last fund: Likely still investing — raised $108M in 2023

Portfolio highlights

  • Reduciner — Reduciner's vision to turn industrial CO₂ emissions from a liability into a valuable resource. Its technology converts captured carbon dioxide and biochar into valuable feedstocks such as carbon monoxide and activated carbon, enabling circular carbon use in emissions-intensive industries. Reduciner combines strong scientific expertise withindustrial applicability across sectors such as cement, steel, and chemicals. Its electricity-driven process allows industries to reduce emissions without major changes to existing infrastructure, offering a resilient and cost-competitive way to reduce carbon dependency while creating new value from CO₂ emissions.
  • TheStorage — Flexible industrial heat electrification and scalable energy storage. TheStorage offers cost efficient, sustainable grid scale energy storage that can discharge heat, steam or CHP.
  • Photoncycle — The year-round solar energy system for heating and electricity
Show all investments...

Bånt AB
VC Fund · 3 investments in Sweden Biotechnology startups

Bånt AB

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Food Processing
  • Stage:Seed
  • Geography: Sweden

Investor stats

  • Total investments: 3
  • Round size: Seed $1.3M–$9.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
Show all investments...

EIR Ventures
VC Fund · Stockholm, Stockholms Lan, Sweden · 3 investments in Sweden Biotechnology startups

EIR Ventures is a new Life Science Venture Group in the Nordics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed
  • Geography: Denmark, Sweden, United States

Investor stats

  • Total investments: 13
  • Round size: Series A $20M–$73M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $138M in 2021

Portfolio highlights

  • ArgusEye — ArgusEye is a biotechnology company that provides sensor solutions for real-time detection of biological systems and processes. ArgusEye's patented sensor technology is the result of extensive academic research and is based on nanoplasmonic sensing with fiber optics. By adding customized receptors, ArgusEye can offer flexible and sensitivesensing systems for a variety of targets.
  • Moleculent — Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in biological research.
  • Hoba Therapeutics — Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
Show all investments...

BackingMinds
VC Fund · Stockholm, Stockholms Lan, Sweden · 3 investments in Sweden Biotechnology startups

We help great minds unleash their full potential!

Show more...

Investment focus

  • Industry: Software, SaaS, Energy
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Sweden, Denmark, Finland

Investor stats

  • Total investments: 37
  • Round size: Seed $854k–$3.7M; Pre-Seed $826k–$8.2M; Venture - Series Unknown $1.3M–$40M
  • Lead/follow: 59% lead, 41% follow
  • Last fund: Likely still investing — raised $52M in 2022

Portfolio highlights

  • Tavion — Critical energy storage infrastructure for a sustainable future.
  • SNERPA Power — SNERPA Power develops intelligent energy services.
  • Helios Innovations — Helios offers on-site industrial waste management of liquid waste. Reduce waste volume by up to 90% without investment.
Show all investments...

I Love Lund
VC Fund · Lund, Skane Lan, Sweden · 3 investments in Sweden Biotechnology startups

I Love Lund is a venture capital firm.The firm seeks opportunities to invest in pre-seed rounds

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Forestry
  • Stage:Venture - Series Unknown, Pre-Seed, Seed
  • Geography: Sweden

Investor stats

  • Total investments: 7
  • Round size: Pre-Seed $420k–$456k; Venture - Series Unknown $38k–$2.2M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Cyclicor — Cyclicor is an innovations based company focused on the development and commercialisation of safer and more sustainable polymers. The company was registered in October of 2012 as a spin-off company from the University of Lund in Sweden and began commercial development of its first product Cycli-ClearTM, a bisphenol free polycarbonate, in late 2013.
  • Katam Technologies — Katam Technologies helps forestry companies all over the world optimize operations through digitalization, solid data, and planning. With the aid of digitalization, reliable data, and careful planning, Katam assists forestry companies all over the world in maximizing operations. Small businesses and private forest owners can use the Katam app orKatam portal as standalone products to obtain quick and precise measurements.
  • Valkyr Defense Systems — Valkyr specializes in cost-effective, modular, and autonomous defense systems, leveraging commercial off-the-shelf (COTS) technology to fast-track production.
Show all investments...

Inventure
VC Fund · Helsinki, Southern Finland, Finland · 3 investments in Sweden Biotechnology startups

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: Finland, Sweden, United States

Investor stats

  • Total investments: 180
  • Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$25M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — raised $140M in 2022

Portfolio highlights

  • Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
  • Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
  • Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Show all investments...

Partnerinvest Norr
VC Fund · Piteå, Norrbottens Lan, Sweden · 3 investments in Sweden Biotechnology startups

Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors. Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Seed, Venture - Series Unknown
  • Geography: Sweden, United States

Investor stats

  • Total investments: 70
  • Round size: Seed $554k–$2M; Venture - Series Unknown $359k–$4M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: May invest from a new fund soon — raised $32M in 2009

Portfolio highlights

  • Cold River Games — Crystalfall is an upcoming free online action RPG with customizable skills and an endless endgame, set in a steampunk world.
  • Original Creation — Original Creation envisions a sustainable future in which capital is focused on long-term benefits for both people and the environment, and resources are properly managed through circular systems."
  • Remos Space Systems — Remos Space Systems simplifies satellite ground operations.
Show all investments...

Fåhraeus Startup and Growth
VC Fund · Lund, Skane Lan, Sweden · 3 investments in Sweden Biotechnology startups

FSG (Fåhraeus Startup and Growth) is a Lund-based venture capital firm investing at the intersection of life science and tech, including digital health, medtech, diagnostics and life science tools. It invests €1–6M per company from Seed to Series A, selectively Series B.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Sweden, Denmark, Finland

Investor stats

  • Total investments: 14
  • Round size: Seed $851k–$2.7M; Series A $1.8M–$5.9M; Venture - Series Unknown $1.1M–$7.3M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
  • Fida Biosystems — Quantification and characterisation of complex biology made simple. Study molecular interactions in solution, with only nanoliters of sample. Used by industry leaders.
  • Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Flerie Invest
VC Fund · 3 investments in Sweden Biotechnology startups

Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Sweden, United States, United Kingdom

Investor stats

  • Total investments: 28
  • Round size: Series A $2.5M–$21M; Series B $12M–$75M; Venture - Series Unknown $4.5M–$47M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
  • Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Show all investments...

FBG Invest
VC Fund · 3 investments in Sweden Biotechnology startups

FBG Invest

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Food Processing
  • Stage:Seed
  • Geography: Sweden

Investor stats

  • Total investments: 3
  • Round size: Seed $1.3M–$9.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
Show all investments...

Hadean Ventures
VC Fund · Oslo, Oslo, Norway · 3 investments in Sweden Biotechnology startups

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Sweden, Norway, Austria

Investor stats

  • Total investments: 36
  • Round size: Series A $4.2M–$79M; Series B $4.5M–$75M; Venture - Series Unknown $2M–$29M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: Likely still investing — raised $168M in 2021

Portfolio highlights

  • Oncoinvent — Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
  • Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

Colibri Ventures
VC Fund · Solna, Stockholms Lan, Sweden · 2 investments in Sweden Biotechnology startups

Colibri Ventures invest in early-stage life science companies and help accelerate their innovations into commercial products.

Show more...

Investment focus

  • Industry: Gaming, Finance, Wellness
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Sweden, Mexico

Investor stats

  • Total investments: 4
  • Round size: Seed $6M–$6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Mundi — Mundi provides financial, trade development, strategy, freight and reinventing international trade services.
  • Mindforce Game Lab — Mindforce Game Lab creates meaningful games with characters that act as companions on the journey to better health.
  • Pixelgen Technologies — Understand the role of proteins in cellular organization with spatial proteomics. Get ahead in the field of proteomics with us.
Show all investments...

Additio Investment Group
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Sweden Biotechnology startups

Value creation for Healthcare & Life Sciences Ventures through capital, expertise, international network.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A
  • Geography: United Kingdom, Sweden

Investor stats

  • Total investments: 7
  • Round size: Series A $4.3M–$12M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Orthox Ltd. — Founded to commercialise technology developed at Oxford University, Orthox aims to revolutionise the way cartilage injuries are treated. Trauma and erosion of the smooth, stiff cartilage in our joints leads to Osteoarthritis (OA) a debilitating disease, which affects over 300 million patients globally and costs the US economy alone over $128billion each year. Current therapies to repair damaged cartilage focus either on tissue regeneration or on functional replacement; Orthox’s exceptionally strong, resilient, regenerative hydrogel technology, FibroFix™ achieves both these goals, offering a unique solution for the millions of patients suffering from damage to their joints. Initially targeting the knee, Orthox has developed a compelling set of data on lead product FibroFix™ Cartilage which has secured major awards from multiple funding bodies and will shortly enter clinical trials. FibroFix™ technology will then be rolled out to treat other joints and Orthox also has pipeline developments beyond orthopaedics in which strength and tissue regeneration are key. Pipeline expansion is valuable as growth in the annual global biomaterials market will exceed $250 billion by 2025. Orthopaedic biomaterials will form the largest proportion of this and natural biomaterials, like FibroFix™, will be the fastest growing market segment. Orthox: Reducing Pain, Increasing Mobility, Regenerating Strength™.
  • Gedea Biotech — Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as wellas providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.
  • Oxford Endovascular — Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel.This diverts the blood away from the aneurysm, allowing it to heal.
Show all investments...

Länsförsäkringar
VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in Sweden Biotechnology startups

Länsförsäkringar is a Swedish group of public insurance companies.

Show more...

Investment focus

  • Industry: Real Estate, Biotechnology, Manufacturing
  • Stage:Seed, Pre-Seed, Post-IPO Equity
  • Geography: Sweden

Investor stats

  • Total investments: 12
  • Round size: Seed $484k–$1.3M; Post-IPO Equity $48M–$107M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Stendorren Fastigheter — Stendorren Fastigheter is a company involved in the real estate industry. It develops, owns, operates, and maintains industrial, logistical, and warehouse facilities. The business offers adequate and suitable space on fair lease terms through its tenant.
  • pixlbio (formerly Phenaros) — Data-centric drug discovery with AI, Phenomics and Automation.
  • Swedish Logistic Property — Swedish Logistic Property (SLP) specializes in the development and management of logistics properties across Sweden. With a focus on energy efficiency, SLP provides modern logistics solutions tailored to meet the needs of various businesses. The company's portfolio includes strategically located properties designed to support efficientlogistics and supply chain operations. SLP also engages in the acquisition and development of new properties, aiming to expand its footprint in the logistics real estate market. The company's commitment to sustainability is evident in its construction practices and the operation of its logistics facilities.
Show all investments...

Life Science Invest
VC Fund · Bromma, Stockholms Lan, Sweden · 2 investments in Sweden Biotechnology startups

LSI Academy - New education February 2027, read more here

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Biopharma
  • Stage:Seed, Pre-Seed
  • Geography: Sweden

Investor stats

  • Total investments: 6
  • Round size: Seed $682k–$4.6M; Pre-Seed $310k–$500k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Haga Bioscience — Mission Technology Assays Benefits Team Contact us Focus whereit truly matters. In situ RNA detection at single nucleotide resolution, bridging discovery and translation. Our mission Bridging discovery and translation Spatial omics technologies have transformed how we study tissue biology.However, translating these discoveries into robust, actionable biomarkers remains a major bottleneck, limited by a lack of
  • CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
  • SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Show all investments...

Noaber
VC Fund · Lunteren, Gelderland, The Netherlands · 2 investments in Sweden Biotechnology startups

Noaber Ventures invests in initiatives that bring social transformations using information technology.

Show more...

Investment focus

  • Industry: Health Care, Medical, Fitness
  • Stage:Seed, Series A, Pre-Seed
  • Geography: The Netherlands, Israel, Germany

Investor stats

  • Total investments: 20
  • Round size: Seed $423k–$6.3M; Series A $3M–$20M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
  • Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
  • Alba Health — Discover your baby's gut health & microbiome for the best start in life.
Show all investments...

Gunnar Nilsson Cancer Foundation
VC Fund · 2 investments in Sweden Biotechnology startups

Gunnar Nilsson Cancer Foundation

Show more...

Investment focus

  • Industry: Medical, Genetics, Biotechnology
  • Stage:Seed, Series A
  • Geography: Sweden

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • SAGA Diagnostics — SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine,provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits.The SAGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.
Show all investments...

Segulah Medical Acceleration
VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in Sweden Biotechnology startups

Segulah Medical Acceleration is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Series D, Series A, Seed
  • Geography: Sweden, United Kingdom, Germany

Investor stats

  • Total investments: 9
  • Round size: Series A $8.5M–$12M; Series D $34M–$245M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
  • Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
  • Collective Minds — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
LU Holding
VC Fund · 2 investments in Sweden Biotechnology startups

LU Holding is a Lund University’s investment company.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Medical Device
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Sweden

Investor stats

  • Total investments: 4
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • MedVasc — MedVasc has developed Solution a patented medical device that reduces pain when treating varicose veins.
  • Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
  • Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Show all investments...

Faro Capital
VC Fund · Buenos Aires, Distrito Federal, Argentina · 2 investments in Sweden Biotechnology startups

FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally.Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection tobecome the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term.Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.

Show more...

Investment focus

  • Industry: Biotechnology, Gaming, Medical
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: Sweden, United States

Investor stats

  • Total investments: 5
  • Round size: Series A $2.8M–$25M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — raised $115M in 2014

Portfolio highlights

  • Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
  • Bluwhale — Unlock Web3 Wallet Potential with AI Insights. Supercharge Your Business Growth
  • IntuiCell — IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.
Show all investments...

LIU Invest
VC Fund · Linköping, Ostergotlands Lan, Sweden · 2 investments in Sweden Biotechnology startups

LIU invests in companies that are based on projects and ideas from Linköping University. LIU Invest is focused on investments in early phases. Investments are typically 250 000, but can be doubled by an additional investment.

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, AgTech
  • Stage:Seed, Pre-Seed
  • Geography: Sweden

Investor stats

  • Total investments: 9
  • Round size: Seed $579k–$1.4M; Pre-Seed $88k–$282k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.​
  • Sonicflora — Plants have always been speaking. We can now understand them.
  • Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.
Show all investments...

ARCH Venture Partners
VC Fund · Chicago, Illinois, United States · 2 investments in Sweden Biotechnology startups

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, United Kingdom

Investor stats

  • Total investments: 472
  • Round size: Series A $9.1M–$213M; Series B $15M–$230M; Series C $15M–$167M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $3B in 2024

Portfolio highlights

  • Synchron — The endovascular brain computer interface.
  • Ramona — At Ramona, we’re creating a high-throughput microscopy toolset to unlock a new perspective on cellular-level research. With a wider field of view and the capacity to capture data synchronously, we see more — and we see it in motion. By providing a new point of view, our technology enables researchers to make more informed decisions, faster.
  • Moonwalk Biosciences — By deeply profiling and targeting the epigenetic code, Moonwalk aims to reprogram cells to their healthy state, fundamentally enabling a new approach to how therapies are discovered and developed.
Show all investments...

Glass Wall Syndicate
VC Fund · 2 investments in Sweden Biotechnology startups

Glass Wall Syndicate invests in companies and products that will make a difference in the lives of animals, people, and the planet. It helps grow companies in this space by providing them with capital, resources, mentorship, and other forms of support.The firm is consists of a group of venture capitalists, foundations, trusts, non-profits, andindividual investors who share a similar investment thesis and want to accelerate mainstream adoption of products and services that will make a difference in the lives of animals, people and that are better for the planet.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Health Care
  • Stage:Seed, Pre-Seed, Series C
  • Geography: United States, India, Sweden

Investor stats

  • Total investments: 8
  • Round size: Seed $845k–$5.7M; Pre-Seed $1.6M–$2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MeliBio — Discover MeliBio's innovative bee-free honey, promoting a sustainable future for humans and bees. Explore our mission, vision, and impact.
  • Cultured Decadence — Growing real meat directly from animal cells.
  • UNCAGED Innovations — What if we could make leather without the animal? We are a biomaterials company combining the power of nature and technology to reimagine leather.
Show all investments...

Nordic Science Investments
VC Fund · 2 investments in Sweden Biotechnology startups

We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Diagnostics
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden, United States

Investor stats

  • Total investments: 18
  • Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$34M
  • Lead/follow: 83% lead, 17% follow
  • Last fund: Likely still investing — raised $34M in 2024

Portfolio highlights

  • CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
  • mu-ray.tech — MuRay Tech generates a controlled muon beam to image inside solid metal and 3D printed pieces. Non-destructively. In minutes.
  • Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
Show all investments...

Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Sweden Biotechnology startups, 7 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 96
  • Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $52M in 2025

Portfolio highlights

  • Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and better healthcare.
  • Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
  • Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Show all investments...

Bertebos Foundation
VC Fund · 2 investments in Sweden Biotechnology startups

Bertebos Foundation

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Food Processing
  • Stage:Seed
  • Geography: Sweden

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
Show all investments...

Kale United
VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in Sweden Biotechnology startups

Kale United offers a portfolio of over 75+ plant-based game changers

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Sweden, United Kingdom, Canada

Investor stats

  • Total investments: 28
  • Round size: Seed $360k–$2.5M; Pre-Seed $100k–$2M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
  • Hooked Foods — Hooked Foods is working on a plant-based tuna substitute. By serving delicious plant-based seafood for everyone to enjoy, the company is leading the transition to a healthier seafood ecosystem. The company was established in 2019 and is headquartered in Sweden.
  • Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
Show all investments...

Plantbase Foundation
VC Fund · 2 investments in Sweden Biotechnology startups

Plantbase Foundation

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Food Processing
  • Stage:Seed
  • Geography: Sweden

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Mycorena — Mycorena is a fungi-based, next-generation vegan protein and food manufacturing solution to plants, using significantly less resources. Mycorena was established in 2017 and is headquartered in Gothenburg, Sweden.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Inven2
VC Fund · Oslo, Oslo, Norway · 1 investments in Sweden Biotechnology startups

Inven2 specializes in the commercialization of research and to make outstanding research into the industry of the future.

Show more...

Investment focus

  • Industry: Therapeutics, Biotechnology, Pharmaceutical
  • Stage:Series A
  • Geography: Sweden

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Show all investments...

Social Starts
VC Fund · San Francisco, California, United States · 1 investments in Sweden Biotechnology startups

Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: United States, Germany, United Kingdom

Investor stats

  • Total investments: 288
  • Lead/follow: no public data

Portfolio highlights

  • Hey Jane — Get safe, effective and affordable abortion pills delivered fast to your home. Hey Jane is the first digital abortion clinic, connecting you to licensed providers in your state through telemedicine.
  • Mae Health — Mae is a maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes.
  • Wayfinder Biosciences — We design RNA for next generation biomanufacturing and smart therapeutics.
Show all investments...

Monesi
VC Fund · 1 investments in Sweden Biotechnology startups

Monesi is an invesment firm.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Pre-Seed
  • Geography: Sweden

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Phenaros Pharmaceuticals — Data-centric drug discovery with AI, Phenomics and Automation.
Show all investments...

HJKK Didrikson
VC Fund · 1 investments in Sweden Biotechnology startups

HJKK Didrikson operates as an investment firm.

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology, Pharmaceutical
  • Stage:Seed
  • Geography: Sweden

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • AAX Biotech — AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies.
Show all investments...

Phase2Phase Biopharma
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investments in Sweden Biotechnology startups

Phase2Phase Biopharma is a consulting company that offers CMC strategies, CRO, CMO, CDMO sourcing, CMC project management, and QA services.

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology, Pharmaceutical
  • Stage:Seed
  • Geography: Sweden

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • AAX Biotech — AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies.
Show all investments...

Inter Ikea
VC Fund · Luxembourg, Luxembourg, Luxembourg · 1 investments in Sweden Biotechnology startups

Inter IKEA Group's aim is to secure continuous improvement, development, expansion and a long life of the franchising operation.

Show more...

Investment focus

  • Industry: Software, Furniture, Health Care
  • Stage:Seed, Corporate Round
  • Geography: Germany, Sweden, Denmark

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • nyris — Our custom search engines make it easy for people to find products, spare parts, and components for industry and eCommerce
  • NORNORM — High quality pre-loved office furniture, including office design, installation and flexibility to change. Own less, pay less, and change whenever.
  • Seprify — Enabling sustainable products
Show all investments...

Unruly Capital
VC Fund · Italy, Texas, United States · 1 investments in Sweden Biotechnology startups

Investing in the crazy before it becomes normal

Show more...

Investment focus

  • Industry: Biotechnology, CleanTech, Manufacturing
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 49
  • Lead/follow: no public data

Portfolio highlights

  • Ephos — Designing and manufacturing glass-based integrated photonic circuits that power the most advanced classical and quantum devices
  • AtmoCooling — AtmoCooling transforms coastal deserts into thriving hubs of agriculture, clean energy, and climate resilience. It was founded in 2022 and operates in the USA and UAE.
  • Terran Robotics — Terran Robotics is a construction company that specializes in AI and robotics. The company's headquarters are in Bloomington, Indiana.
Show all investments...

Nxt2b
VC Fund · Uppsala, Uppsala Lan, Sweden · 1 investments in Sweden Biotechnology startups

Nxt2b is a venture capital company focused on investments in healthcare, pharmaceuticals companies, and medical devices.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Series A
  • Geography: Sweden

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
Show all investments...

KTH Holding
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investments in Sweden Biotechnology startups

KTH Holding is a state-owned limited company managed by KTH's University Board. It invests in promising startup companies that are based on research or teaching at KTH, with the aim of supporting commercialization and making it easier for new science to benefit society.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Pre-Seed
  • Geography: Sweden

Investor stats

  • Total investments: 21
  • Lead/follow: no public data

Portfolio highlights

  • Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.​
  • porkchop — In-space logistics for SmallSats in Low Earth Orbit and beyond.
  • Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
Show all investments...

Nordic Foodtech VC
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Sweden Biotechnology startups

We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food

Show more...

Investment focus

  • Industry: Biotechnology, Life Science, Water
  • Stage:Seed, Series A
  • Geography: Finland, Sweden, Denmark

Investor stats

  • Total investments: 26
  • Lead/follow: no public data

Portfolio highlights

  • EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
  • Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
  • Happy Plant Protein — Revolutionize plant protein production with Happy Plant Protein's innovative technology, transforming local ingredients into high-quality, sustainable solutions for the food industry.
Show all investments...

Biotechnology VC funding in Sweden at a glance

Stats across 435 deals from 331 investors.

331
investors
in Sweden Biotechnology startups
435
deals
in Sweden Biotechnology startups
$2.2M
median round
in Sweden Biotechnology startups
43%
lead investors
lead at least one round
23%
Grant
most common funding stage

Access all 331 VC funds in Sweden Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology VC Funds in Sweden investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 331 VC funds investing in Sweden Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists